DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT02527421 · TERMINATED
Trial details
- NCT number
- NCT02527421
- Sponsor
- Primus Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-19
- Primary completion
- 2019-03-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.